NCT06699992View on ClinicalTrials.gov

Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study

Not yet recruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 1, 2024

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
Cognitive Decline
Interventions
DIAGNOSTIC_TEST

Blood biomarkers quantification

Blood biomarkers quantification

Trial Locations (1)

00168

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

All Listed Sponsors
collaborator

Istituto Superiore di Sanità

OTHER

collaborator

Azienda Ospedaliera dei Colli

OTHER

collaborator

Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone Palermo

OTHER

collaborator

A.O.U. Città della Salute e della Scienza

OTHER

collaborator

Neurologia Arzignano AULSS8 Berica

UNKNOWN

collaborator

Azienda Ospedaliero-Universitaria di Modena

OTHER

lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06699992 - Clinical Application and Usability of Blood Biomarkers As Screening Tool in Alzheimer Disease: a Validation Study | Biotech Hunter | Biotech Hunter